A recent meta-analysis of 20 double-blind, randomized, placebo-controlled trials, encompassing 64,984 participants, was conducted to determine the impact of PCSK9-iTs on the occurrence of sepsis and other severe infections. Here, PCSK9 is linked to Sepsis.